Atlas Trials

Effect Levosimendan Administration on Postoperative NT-proBNP in Cardiac Risk Patients

Clinical trial NCT04329624 · COMPLETED

Trial details

NCT number
NCT04329624
Sponsor
Medical University of Vienna
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Cardiovascular Risk Factor
Start date
2020-10-10
Primary completion
2023-11-07
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.